News

Expert Julie Hurley will address pitfalls in "Securing and Illuminating the Pharmaceutical Supply Chain" webinar Wednesday.

If CSR payments are halted, 42 percent of payers said they'd likely withdraw from the market, while the rest would raise rates.

CEOs of Greenville and Palmetto will continue to serve as co-CEOs of the new not-for-profit company.

Most of that reflects the significant increase in private insurance enrollment during that period, which was greater in those states.

Some of the policies under consideration have slipped out, and pressure points of the debate are fairly clear.

Documents reveal behind-the-scenes discussions influenced by pharmaceutical industry, led by former Gilead lobbyist Joe Grogan.

If there's one point a recent session at America's Health Insurance Plans Institute & Expo 2017 brought home, it's that if providers and payers are going to manage their members as a population, they need to start by knowing them individually.

Effective immediately, Cigna may resume marketing of its Medicare Advantage-prescription drug and Medicare Part D plans.

Conroy, current CEO of Lahey Hospital in Massachusetts, replaces James Weinstein, who steps down June 30.

The healthcare administrative services and IT provider took over a year to notify 220,000 individuals of a breach to its website. HHS is determining if it's a HIPAA-covered business associate.